34 Items, 2 Pages <<Prev 1 2 Next>> All
| No. | Name of Lifestyle | Third Class | Second Class | First Class | Type | No. of Studies |
|---|---|---|---|---|---|---|
| 1 | Acetaminophen | Analgesic and anti-inflammatory drugs | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 2 | Age at first of Anticoagulants | Anticoagulants | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 3 | Antidiabetic drug | Antidiabetic | Drug | Clinical characteristics | Protective factor Risk factor No statistical significance factor | 1 |
| 4 | antihypertensive | Antihypertensive | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 5 | Aspirin | Analgesic and anti-inflammatory drugs | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 6 | Benign prostatic hypertrophy medication | Benign prostatic hypertrophy(BPH) medication | Drug | Clinical characteristics | Protective factor Risk factor No statistical significance factor | 1 |
| 7 | Blood pressure medication | Antihypertensive | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 8 | Cholesterol-lowering drugs | Cholesterol-lowering drugs | Drug | Clinical characteristics | Protective factor No statistical significance factor | 1 |
| 9 | Cimetidine | Antiulcer drug | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 10 | Cumulative use of Cimetidine | Antiulcer drug | Drug | Clinical characteristics | Risk factor No statistical significance factor | 1 |
| 11 | Cumulative use of Other H2 blockers | Antiulcer drug | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 12 | Current of Anticoagulants | Anticoagulants | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 13 | current vs.non- of Statin | Statin | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 14 | Duration of us of Anticoagulants | Anticoagulants | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 15 | Fibrates | Cholesterol-lowering drugs | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 16 | Finasteride | Benign prostatic hypertrophy(BPH) medication | Drug | Clinical characteristics | Protective factor | 1 |
| 17 | Ibuprofen | Analgesic and anti-inflammatory drugs | Drug | Clinical characteristics | Risk factor No statistical significance factor | 1 |
| 18 | Indication of Anticoagulants | Anticoagulants | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 19 | Insulin | Antidiabetic | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 20 | Ketoprofen | Analgesic and anti-inflammatory drugs | Drug | Clinical characteristics | No statistical significance factor | 1 |